North Star Investment Management Corp. Marker Therapeutics, Inc. Transaction History

North Star Investment Management Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$1.5 - $2.2 $625 - $917	-417 Closed	0 $0
Q3 2019 Oct 03, 2019	BUY	$4.1 - $9.0 $1,709 - $3,753	417 New	417 $2,000
Q2 2019 Jul 15, 2019	SELL	$5.15 - $7.92 $2,147 - $3,302	-417 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$4.2 - $9.74 $1,751 - $4,061	417 New	417 $2,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $286M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.